Skip to main content

Immunotherapy for Non-melanoma Skin Cancer

TO REGISTER: Scroll down and and add to cart
ASDS Fellow Members, Residents: $99
Non-Member Dermatologists: $199

Live Event: Thursday, June 2, 2022 | 6:00-7:00 pm CT
On-Demand: This educational activity will be presented live and will be available on-demand 24-48 hours post-event.

Faculty
Emily Ruiz, MD, MPH
Abigail Waldman, MD, MHS

Description

Immunotherapy for non-melanoma skin cancer" will use real-world cases to discuss the role of immunotherapy in the treatment of non-melanoma skin cancer. The webinar will include a summary of data for immunotherapy for non-melanoma skin cancers as well as a discussion of adverse events.

Learning Objectives
At the conclusion of this activity, participants should be able to:
  • To define non-melanoma skin cancers that could benefit from immunotherapy.
  • To summarize available immunotherapies for non-melanoma skin cancers.
  • To discuss outcomes and adverse events associated with immunotherapy for non-melanoma skin cancers.

CME: 1.00 AMA PRA Category 1 Creditâ„¢
To obtain CME credit in your ASDS Learn profile and download your CME certificate, you will need to view the webinar and complete the attendee evaluation.
The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.